Skip to main content
Cardiovascular Diseases logoLink to Cardiovascular Diseases
. 1981 Sep;8(3):372–378.

Increased release of beta thromboglobulin during acute myocardial infarction

Richard E Ward 1, Jannie Woo 1, Paul Pace 1
PMCID: PMC287958  PMID: 15216194

Abstract

Beta thromboglobulin (βTG) is a platelet-specific protein released during platelet aggregation. To classify the role of platelet aggregation in acute myocardial infarction (AMI), βTG levels were measured by means of a specific and highly sensitive radioimmunoassay in patients admitted to the Coronary Care Unit for the evaluation of acute chest pain. These levels were compared to creatine phosphokinase (CPK) values and the percentage of myocardial fraction (MB), as well as electrocardiographic criteria for AMI. Beta thromboglobulin was considered elevated when it was greater than 132 μ/1. The CPK and MB fraction were considered to indicate AMI if there was an increase of MB fraction greater than 5% of the total CPK and a progressive increase of the total CPK and MB fraction during the course of the disease. Ten patients were compared to 28 control subjects. Seven patients had electrocardiographic evidence of AMI in addition to CPK and MB criteria. Six of these patients also had elevated βTG values, whereas one did not. This patient was admitted late during his clinical course, as evidenced by the CPK-MB curve. Of the three patients without clinical evidence of AMI, two had normal βTG levels, whereas the third patient had one normal βTG level and one mildly elevated level. This study implicates the role of platelet aggregation in AMI and suggests its potential usefulness as a diagnostic aid in evaluating acute chest pain.

Full text

PDF
372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  2. Handin R. I., McDonough M., Lesch M. Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med. 1978 Feb;91(2):340–349. [PubMed] [Google Scholar]
  3. Ludlam C. A., Bolton A. E., Moore S., Cash J. D. New rapid method for diagnosis of deep venous thrombosis. Lancet. 1975 Aug 9;2(7928):259–260. doi: 10.1016/s0140-6736(75)90967-8. [DOI] [PubMed] [Google Scholar]
  4. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res. 1975 Jun;6(6):543–548. doi: 10.1016/0049-3848(75)90066-3. [DOI] [PubMed] [Google Scholar]
  5. Mercer D. W., Varat M. A. Detection of cardiac-specific creatine kinase isoenzyme in sera with normal or slightly increased total creatine kinase activity. Clin Chem. 1975 Jul;21(8):1088–1092. [PubMed] [Google Scholar]
  6. Moore S., Pepper D. S., Cash J. D. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta. 1975 Feb 27;379(2):360–369. doi: 10.1016/0005-2795(75)90143-9. [DOI] [PubMed] [Google Scholar]

Articles from Cardiovascular Diseases are provided here courtesy of Texas Heart Institute

RESOURCES